Next Re SIIQ S.p.A. (BIT:NR)
Italy · Delayed Price · Currency is EUR 3.040
-0.140 (-4.40%)
At close: Aug 8, 2025, 5:30 PM CET
Intra-Cellular Therapies Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 5.4 | 6.48 | 6.39 | 5.82 | 5.98 | 5.98 | Upgrade |
| 5.4 | 6.48 | 6.39 | 5.82 | 5.98 | 5.98 | Upgrade | |
Revenue Growth (YoY) | -18.08% | 1.41% | 9.70% | -2.71% | 0.10% | 9.97% | Upgrade |
Cost of Revenue | 0.53 | 0.7 | 0.51 | 0.69 | 1.76 | 0.61 | Upgrade |
Gross Profit | 4.87 | 5.77 | 5.88 | 5.13 | 4.22 | 5.36 | Upgrade |
Selling, General & Admin | 2.72 | 2.8 | 5.56 | 5.19 | 4.42 | 3.39 | Upgrade |
Other Operating Expenses | 0.84 | 0.92 | 0.94 | 0.58 | 1.49 | 1.07 | Upgrade |
Operating Expenses | 3.67 | 3.82 | 6.61 | 5.98 | 6.29 | 4.62 | Upgrade |
Operating Income | 1.19 | 1.95 | -0.74 | -0.85 | -2.07 | 0.75 | Upgrade |
Interest Expense | -0.75 | -1.38 | -1.5 | -1.66 | -1.46 | -2.27 | Upgrade |
Interest & Investment Income | 0.12 | 0.15 | 0.04 | 0 | 0.02 | 0 | Upgrade |
Other Non Operating Income (Expenses) | 0.53 | 0.01 | - | -0 | -0.01 | -1.66 | Upgrade |
EBT Excluding Unusual Items | 1.1 | 0.72 | -2.2 | -2.5 | -3.52 | -3.19 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -0.02 | -0.05 | -0.81 | -1.79 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.68 | - | - | Upgrade |
Asset Writedown | -10.83 | -10.65 | -6.97 | 2.89 | 4.76 | -4.3 | Upgrade |
Other Unusual Items | 11.53 | 11.53 | - | - | -0 | -0.61 | Upgrade |
Pretax Income | 1.79 | 1.6 | -9.19 | 1.02 | 0.42 | -9.88 | Upgrade |
Income Tax Expense | -0.02 | -0.02 | 0.25 | 0.67 | -0 | -0.56 | Upgrade |
Earnings From Continuing Operations | 1.81 | 1.61 | -9.44 | 0.35 | 0.43 | -9.32 | Upgrade |
Net Income | 1.81 | 1.61 | -9.44 | 0.35 | 0.43 | -9.32 | Upgrade |
Net Income to Common | 1.81 | 1.61 | -9.44 | 0.35 | 0.43 | -9.32 | Upgrade |
Net Income Growth | - | - | - | -17.57% | - | - | Upgrade |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 13 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 13 | Upgrade |
Shares Change (YoY) | -0.01% | - | - | - | 72.05% | 19.00% | Upgrade |
EPS (Basic) | 0.08 | 0.07 | -0.43 | 0.02 | 0.02 | -0.73 | Upgrade |
EPS (Diluted) | 0.08 | 0.07 | -0.43 | 0.02 | 0.02 | -0.73 | Upgrade |
EPS Growth | - | - | - | -17.57% | - | - | Upgrade |
Free Cash Flow | 0.93 | 2.99 | -2.16 | 0.19 | -17.14 | -2.17 | Upgrade |
Free Cash Flow Per Share | 0.04 | 0.14 | -0.10 | 0.01 | -0.78 | -0.17 | Upgrade |
Dividend Per Share | 0.060 | 0.060 | - | - | - | - | Upgrade |
Gross Margin | 90.24% | 89.14% | 92.06% | 88.12% | 70.55% | 89.74% | Upgrade |
Operating Margin | 22.14% | 30.08% | -11.52% | -14.52% | -34.58% | 12.46% | Upgrade |
Profit Margin | 33.49% | 24.93% | -147.82% | 6.04% | 7.13% | -155.92% | Upgrade |
Free Cash Flow Margin | 17.31% | 46.14% | -33.75% | 3.21% | -286.37% | -36.33% | Upgrade |
EBITDA | 1.27 | 2.04 | -0.62 | -0.65 | -1.69 | 0.76 | Upgrade |
EBITDA Margin | 23.56% | 31.45% | -9.77% | -11.09% | -28.18% | 12.79% | Upgrade |
D&A For EBITDA | 0.08 | 0.09 | 0.11 | 0.2 | 0.38 | 0.02 | Upgrade |
EBIT | 1.19 | 1.95 | -0.74 | -0.85 | -2.07 | 0.75 | Upgrade |
EBIT Margin | 22.14% | 30.08% | -11.52% | -14.52% | -34.58% | 12.46% | Upgrade |
Effective Tax Rate | - | - | - | 65.42% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.